Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-31
DOI
10.1038/s41598-017-15026-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabinoids and autoimmune diseases: A systematic review
- (2016) Valeria Katchan et al. AUTOIMMUNITY REVIEWS
- Linking in Vitro Lipolysis and Microsomal Metabolism for the Quantitative Prediction of Oral Bioavailability of BCS II Drugs Administered in Lipidic Formulations
- (2016) Paloma Benito-Gallo et al. MOLECULAR PHARMACEUTICS
- Effects of pro-inflammatory cytokines on cannabinoid CB1and CB2receptors in immune cells
- (2015) L. Jean-Gilles et al. Acta Physiologica
- Cannabis in cancer care
- (2015) DI Abrams et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Development of a simple and sensitive HPLC–UV method for the simultaneous determination of cannabidiol and Δ9-tetrahydrocannabinol in rat plasma
- (2015) Atheer Zgair et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Targeted delivery of a model immunomodulator to the lymphatic system: Comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies
- (2014) Sifei Han et al. JOURNAL OF CONTROLLED RELEASE
- IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells
- (2014) R. Noster et al. Science Translational Medicine
- Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
- (2014) Felix J. Hartmann et al. Nature Communications
- Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction
- (2013) Rebecca Hartzell Robinson et al. Journal of Neuroimmune Pharmacology
- The immune modifying effects of amino acids on gut-associated lymphoid tissue
- (2013) Megan R Ruth et al. Journal of Animal Science and Biotechnology
- The linkage of innate and adaptive immune response during granulomatous development
- (2013) Toshihiro Ito et al. Frontiers in Immunology
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: Linear correlation with oral bioavailabilities in rats
- (2011) Minghui Sun et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cytokines in Autoimmunity: Role in Induction, Regulation, and Treatment
- (2011) Kamal D. Moudgil et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- GM-CSF: the secret weapon in the TH17 arsenal
- (2011) Mandy J McGeachy NATURE IMMUNOLOGY
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
- (2011) Mohamed El-Behi et al. NATURE IMMUNOLOGY
- Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol
- (2011) Venkatesh L. Hegde et al. PLoS One
- Diagnostic Necropsy and Selected Tissue and Sample Collection in Rats and Mice
- (2011) Christina M. Parkinson et al. Jove-Journal of Visualized Experiments
- Targeted Drug Delivery to Lymphocytes: A Route to Site-Specific Immunomodulation?
- (2010) Natalie L. Trevaskis et al. MOLECULAR PHARMACEUTICS
- Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
- (2009) Francesca Borrelli et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Δ9-Tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro
- (2009) Marcel Jenny et al. JOURNAL OF NEUROIMMUNOLOGY
- The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)
- (2008) Barbara L.F. Kaplan et al. BIOCHEMICAL PHARMACOLOGY
- Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Δ9 -tetrahydrocannabinol
- (2008) Alison E. B. Springs et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cannabidiol arrests onset of autoimmune diabetes in NOD mice
- (2007) Lola Weiss et al. NEUROPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now